Authors
Loading...
Review highlights interconnections among metabolic dysfunction-associated steatotic liver disease, cardiovascular disease, and chronic kidney disease, suggesting new management approaches.
Moncho et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: